So now you want to drag me into this Ryn and looking for someone to blame with ref the drug
i would appreciate it if you could pull that up for me
Yes once upon a time i was positive very positive on this stock
the only times we clashed was when you saw me being negative or your interpretation of my being negative
If indeed i did say what you say, should you have taken my word for it off course not
Not to long ago wasnt AF your best buddy you would not hear any bad said against the guy same for CG and JG now all of a sudden you want to sack the fkn lot how does that work at least i have been consistant i have always told it as i saw fit, which is one of the things i suppose you despise about me, you never could understand why i spoke negative about a company i was invested in well this has hit the fan but at least i have stood by my beliefs and not turned and changed my tune as you would appear to have done.
All of a sudden everything stinks when not to long ago you would not hear a bad word against these people oh the sheer strength of the $$$ and how it changes people lol
and now you are talking malpractice here who is actually the joke here lol
I have no idea how long you have been here Ryn but i would just like to pull this up from back in 2019 with ref to the drug manufacture
Below is a a post i put up in 2019
This post got 3 TU against goerges follow on post of 24TU
Date:22/11/19
Time:15:58:17
Post #:
41582839Thanks for your thoughts Uboy
12 months yes maybe 10 months dosing and 2 month wash out if this is what it's taking over the lower dose trial
As you say don't want to poison the kids
But 100mg
Don't forget the trials are monitored could this be split
Into two groups maybe 100 and 200
Placebo good point plus the fact as you say the drug has shown effect in this trial
Where would the trials be held here or in the EU
If here in ozz then wonder if this original 9 would participate in the follow up trial or follow the trial to the EU if it has to be carried out over seas
Big question is will the Diamond get the new product manufactured by the same companyI wonder has he learned his lessonI wonder just what expense he cost us in our valuable funds wasted on a drug that will probably go past it's use by date or is totally unusable for any further trials in acromegaly
Nice one diamond wonder if anyone will bring that misdemeanour up at the AGM lol
Thanks Uboy
or this one from 2020 extracts from and questions asked back in the day Date:14/05/20
Time:03:12:58
Post #:
44607862I am sorry but I feel I have to jump in here firstly with ref your first paragraph is utter crock
sorry Mac
and as for asking Imp to make an apology
For what, what does imp have to apologies for
For being impatient give me a break Mac you have got to be Frgn kidding me surely
You then go on to post a Co Ann which I presume you are trying to defend them with which actually lays down just exactly how incompetent they really are in that the Atl 1103 fell down because they did not manufacture the drug through the initial manufacturer
Yet you and your thumbs up brigade appear to dismiss this failure along with all its expense and seem to accept this as the norm to me this is inexcusable
A $450k a year director should be better than this, no excuse sorry
You tell Imp to ring the director for what to be given a load of flannel
DEFINE FLANNEL
OK LETS DEFINE FLANNEL
Back in 2016 I put up a number of questions to this board at the AGM by notice as I could not attend, those questions were backed by a certain number of shareholders that were just not happy with the way things were being run, I cannot remember if it was the first strike we achieved or the second strike which we achieved but these were the questions and answers we received
Take a good read to their replies Mac and tell Both myself and Imp and a number of others that have been around for the journey, that its not a case of being patient its a case of disclosure @ market ( OR LACK OF and FOLLOW THROUGH ON ANN MADE )
and you say ask the question WHY just look at the replies we got, Go through the history search some of their replies can you verify from those questions anything they actually followed through on
2014 we received the go ahead from the FDA to submit a plan yet here we sit still seeking that go ahead and that all illusive grant funding etc etc etc
And you accept this constant garbage and tell folks to be patient or move on LOL
Question from that post that i asked see 3 below
3. It is Vaguely understood as nothing was ever announced that the previous samples that were supposedly going to be available for the EAP, had obviously gone by their use by date, hence the Ann to the market that a new batch had to be processed (what was the shelf life of the previous Batch) could it be that this latest batch that has been made up, will be totally unusable by the time that the EAP actually gets underway hence being a total waste of company funds?REPLYATL1102, like other oligonucleotide drugs of its class, is inherently stable. The formulated ATL1102 drug product that was manufactured for the EAP has been assigned a provisional label expiry in 2018. However, as required by regulatory guidelines, both the API and formulated product remain under stability testing for the duration of its intended use and further reviews of the stability data as it becomes available is expected to justify additional extensions. Based on our experience with previous batches of ATL1102, the company is confident of an extension of 4 or more years from the date of manufacture to be justified for the current batch. For personal use only
That was from back in 2020 and they forecast an extended time of 4 more years so you tell me Ryn
And you call myself and Gassy a joke
at least we both remained steadfast in our beliefs
If you are looking for someone to blame Ryn perhaps take a long hard look at yourself before you start casting stones
dont try to lay blame elswhere for your own shortcomings its most definately not a good look
I wish you well with your investment in DXB
I will not engage with you any further
(20min delay)